Resultados de la búsqueda 121-130 of 17322 for wbc

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Multiple myeloma (MM) is a blood cancer that affects a type of white cell called plasma cell. It mainly affects older individuals and has an average age at ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Multiple myeloma (MM) is a blood cancer that affects a type of white cell called plasma cell. It mainly affects older individuals and has an average age at ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.

  9. Hematología - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.